Correlation Between Equillium and Serina Therapeutics

Can any of the company-specific risk be diversified away by investing in both Equillium and Serina Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Equillium and Serina Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Equillium and Serina Therapeutics, you can compare the effects of market volatilities on Equillium and Serina Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Equillium with a short position of Serina Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Equillium and Serina Therapeutics.

Diversification Opportunities for Equillium and Serina Therapeutics

0.63

Correlation Coefficient

Equillium  Serina Therapeutics

Poor diversification

The 3 months correlation between Equillium and Serina is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Equillium and Serina Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Serina Therapeutics and Equillium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Equillium are associated (or correlated) with Serina Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Serina Therapeutics has no effect on the direction of Equillium i.e., Equillium and Serina Therapeutics go up and down completely randomly.

Pair Corralation between Equillium and Serina Therapeutics

Allowing for the 90-day total investment horizon Equillium is expected to under-perform the Serina Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Equillium is 2.63 times less risky than Serina Therapeutics. The stock trades about -0.18 of its potential returns per unit of risk. The Serina Therapeutics is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  490.00  in Serina Therapeutics on September 22, 2024 and sell it today you would earn a total of  110.00  from holding Serina Therapeutics or generate 22.45% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Equillium  vs.  Serina Therapeutics

Equillium

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Equillium has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Equillium is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Serina Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Serina Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's technical and fundamental indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Equillium and Serina Therapeutics

The main advantage of trading using opposite Equillium and Serina Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Equillium position performs unexpectedly, Serina Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Serina Therapeutics will offset losses from the drop in Serina Therapeutics' long position.

The idea behind Equillium and Serina Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.